Chemical Structure (Lac07 0000 01)
Lacosamide Injection
Product Images NDC 65219-204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 65219-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lac07 0000 02)
Figure 2 (Lac07 0000 03)
Fresenius Kabi Logo (Lac07 0000 04)
Fresenius Kabi Logo (Lac07 0000 05)
Principal Display Panel – 20 mL Vial Label (Lac07 0000 06)
This is a description of Lacosamide Injection, USP. This medication comes in a single-dose vial of 20 mL, with each mL containing 10 mg of Lacosamide. This medication is for intravenous use only and its usual dosage should be seen in the package insert. Any unused portion of the medication should be discarded. This medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F to 86°F). Keep away from children. The medication is manufactured by Fresenius Kabi in Lake Zurich, IL, and has a Lot/Exp number of 403846.*
Principal Display Panel – 20 mL Tray Label (Lac07 0000 07)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
